Adagrasib

What is Adagrasib?

Adagrasib is a targeted cancer therapy used to treat non-small cell lung cancer (NSCLC) with the KRAS G12C mutation. It works by inhibiting the KRAS G12C protein, blocking the growth and survival of cancer cells with this mutation.

How to Use Adagrasib?

Adagrasib is taken orally, as prescribed by your healthcare provider, typically twice a day. Follow the dosing instructions closely.

Side Effects

Common side effects include diarrhea, nausea, and fatigue. Serious side effects may include liver damage and lung inflammation.

Precautions

Inform your doctor if you have liver or lung conditions. Routine monitoring may be required during treatment.

How to Store Adagrasib?

Store at room temperature, away from moisture and heat. Keep the medication out of reach of children and follow proper disposal guidelines for unused doses.